First Analysis Upgrades Catalent, Inc. (NYSE:CTLT) From Neutral To Outperform With Target Price Of $ 43.00

Catalent, Inc. (NYSE:CTLT) upgraded by First Analysis to Outperform from Neutral rating. The research firm cuts target price to $ 43.00 down from previous mark of $ 47.00.

According to the previous trading day, closing price of CTLT was $ 36.11, representing a 5.43 % increase from the 52 week low of $ 34.25 and a 24.57 % decrease over the 52 week high of $ 47.87.

Catalent, Inc. has a market capital of $ 5.56 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.

 

Be the first to comment

Leave a Reply